国产人妖在线视频I午夜av一区二区三区I国产色一区二区I一级片视频在线观看I一级毛片儿I亚色图I丁香花一区二区I超碰97在线免费I久久精品中文字幕I日韩在线视频观看免费I无码中文字幕色专区I欧美专区亚洲专区I国产tv在线观看I2024最新黄色网址I日本老妇高潮乱hdI成人免费入口I日韩精品视频在线看I国产传媒在线播放I一本岛视频在线观看I自拍日韩亚洲一区在线I国产成人亚洲综合a∨婷婷I国产精品2019I色亚洲天堂Iav黄色免费I欧美大尺度视频

Biocompatible nanomicelles for sensitive detection and photodynamic therapy of early-stage cancer

Early-stage tumors are characterized by their small size and scarce secreted markers, and the lack of sensitive detection techniques and reagents, which hinder timely cancer treatment. The natural product pyromagnesium chlorophyll-a (PPa) and FDA approved Pluronic F127 were prepared for F127-PPa nanogel micelles with good size, fluorescence and good biocompatibility. After intravenous injection, F127-PPa nanosized micelles can not only accurately identify early xenograft tumors, but can also be sensitive to detect lung cancer metastasis by near-infrared (NIR) fluorescence imaging. The fluorescence signal was consistent with radionuclide imaging, photoacoustic (PA) imaging, and bioluminescence imaging of the tumors. Furthermore, the fluorescence intensity of small tumors was associated linearly with tumor mass, with a range of 10 – 120 mg and a fluorescence coefficient of 4.5 107 mg – 1. Under the guidance of multimodal imaging, F127-PPa can completely eradicate the effective reactive oxygen species (ROS) generation. These findings may provide clinically translatable drugs and strategies for sensitive diagnosis of early tumors and timely cancer therapy.